Search results for "Thrombosis."

showing 10 items of 624 documents

Is digital necrosis in COVID-19 caused by neutrophil extracellular traps: Potential therapeutic strategies

2021

Some of the COVID-19 patients present with ischemic lesions of their finger and toes. Standard anticoagulant therapy is usually unsuccessful for the treatment of this unique presentation of COVID-19. In this review current evidence is presented, which supports the hypothesis that these necrotic lesions are primarily related to the formation of neutrophil extracellular traps is blood vessels. Also, currently available and potential pharmaco-logical methods of the management of this unique thrombotic complication are discussed. Drugs that possibly could be used in COVID-19 patients suffering from acute ischemia of distal parts of the extremities particularly comprise DNase I and DNase1L3, whi…

Extracellular TrapsNecrosisNeutrophilsIschemiaPharmacologyExtracellular TrapsNeutrophil extracellular trapsArticleNecrosisDNaseAntithromboticmedicineExtracellularHumansDigital ischemiaSARS-CoV-2business.industryCOVID-19ThrombosisGeneral MedicineHeparinNeutrophil extracellular trapsmedicine.diseaseDipyridamolemedicine.symptombusinessmedicine.drugMedical Hypotheses
researchProduct

Pain assessment and management in Italian Haemophilia Centres

2021

BACKGROUND: Although the widespread use of factor VIII/IX replacement therapy has significantly reduced the severity of arthropathy in persons with haemophilia (PWH), some develop degenerative joint changes, associated with significant pain. The aim of this survey was to investigate the management and perception of pain among Italian physicians who treat PWH. MATERIALS AND METHODS: Between September and October 2017, a questionnaire was distributed to 35 Italian haemophilia treatment centres (60 physicians). RESULTS: Fifty-three haemophilia specialists completed the survey. We found that there was good agreement (98.1%) on the need to investigate pain at each clinical visit, but there was h…

Factor IXItalyHumansPain Managementpain heamophiliaHemophilia Ablood coagulation disorders haemophilia pain perception pain management surveysHaemostasis and ThrombosisPain Measurement
researchProduct

Long Term Results After Repair of Type A Acute Aortic Dissection According to False Lumen Patency.

2009

Background. Late survival and freedom from retreatment on the descending aorta was evaluated after ascending aortic repair for type A acute aortic dissection (TAAAD). Methods. Between March 1992 and January 2006, 189 TAAAD patients (mean age, 52 11; range, 17 to 83 years) were included; of these, 58 had a patent false lumen, and 49 had Marfan syndrome. The descending aorta was evaluated postoperatively with computed tomography (CT). Late outcomes were assessed by Cox regression analysis and actuarial survival and freedom from retreatment by the Kaplan-Meier method. Mean follow-up was 88 44 months. Results. There were 38 (20%) late deaths. At 10 years, survival was 89.8% 2.1% for patients wi…

False Lumen PatencySettore MED/23 - Chirurgia CardiacaFollow-up False lumen thrombosis aortic dissection
researchProduct

Persistance of residual vein thrombosis after an episode of deep vein thrombosis of the lower limbs and the risk of new cancer and cardiovascular dis…

2006

8531 Background: In patients with a first episode of idiopathic or provoked Deep Vein Thrombosis (DVT), the presence of Residual Vein Thrombosis (RVT), detected by UltraSonography (US) at the 3rd month from the index DVT, is an independent risk factor for developing recurrent Venous Thromboembolism (VTE) in the subsequent 2 years. Its absence can safely permit to stop Oral Anticoagulants (OA). At the present, it is unknown whether RVT may also identify patients at increased risk for developing cancer and/or cardiovascular disease (CD). In patients with previous DVT of the lower limbs, we conducted a prospective study for evaluating the correlation between RVT findings and the risk of new c…

First episodeCancer Researchmedicine.medical_specialtybusiness.industryIncidence (epidemiology)Deep veinCancerDiseasemedicine.diseaseGastroenterologyThrombosisSurgerymedicine.anatomical_structureOncologyInternal medicinemedicinecardiovascular diseasesRisk factorProspective cohort studybusiness
researchProduct

Peripheral circulating cells with paroxysmal nocturnal haemoglobinuria phenotype after a first episode of cerebral sinus vein thrombosis: Results fro…

2019

Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, potentially fatal disorder of haematopoietic stem cells caused by mutations in an X-linked gene called phosphatidylinositol glycan class A, characterised by intravascular haemolysis, bone marrow failure and thrombotic events. The disease can occur at any age, although preferentially it affects young adults; its estimated prevalence is about 1/500,000 [1]. Clinical symptoms are variable and can include haemolytic anaemia, moderate to severe impairment of haematopoiesis and, in approximately 40% of patients, thrombosis of the vessels of the abdomen, brain and skin [2]. Rare, atypical site thrombosis of the splanchnic veins or cerebral sinu…

First episodemedicine.medical_specialtybusiness.industryCross-sectional studyHemoglobinuria ParoxysmalThrombosisHematologymedicine.diseasePhenotypePeripheralVein thrombosisVenous thrombosisCross-Sectional StudiesPhenotypeInternal medicinemedicineCardiologyHumansParoxysmal nocturnal haemoglobinuriaRisk factorbusinessCerebral sinus venous thrombosisPNHRisk factorScreeningVenous thrombosis
researchProduct

Residual Vein Thrombosis Improves Screening for Occult Cancer: Results On 537 Patients with Idiopathic Deep Vein Thrombosis

2009

Abstract Abstract 3999 Poster Board III-935 Background Clinical advantage of extensive screening for occult cancer in patients with idiopathic Deep Vein Thrombosis (DVT) is unknown. We have demonstrated that the Residual Vein Thrombosis (RVT)-based screening for occult cancer improves early detection as well as cancer-related mortality (Siragusa S et al. Blood 2007;110(699):OC). Here we report on final analysis of 537 patients over a period of 8 years. Objective of the study We conducted a prospective study evaluating whether a RVT-based screening for cancer is sensitive and influences cancer-related mortality. Study design Prospective with two cohorts of DVT patients: the first cohort was …

First episodemedicine.medical_specialtymedicine.diagnostic_testbusiness.industryDeep veinImmunologyCancerColonoscopyCell BiologyHematologymedicine.diseaseBiochemistryOccultSurgerycancer residual vein thrombosisSettore MED/15 - Malattie Del Sanguemedicine.anatomical_structureInternal medicineCohortCancer screeningmedicineProspective cohort studybusiness
researchProduct

Cancer-Related Venous Thrombosis: Residual Vein Thrombosis Improves Screening for Occult Cancer.

2007

Abstract Background. Clinical advantages of extensive screening for occult cancer in patients with idiopathic Deep Vein Thrombosis (DVT) is still debated since this approach improves early detection of cancer but not cancer-related mortality. Recently, we have demonstrated that patients with Residual Vein Thrombosis (RVT), 3 months after DVT, have a high risk for cancer in the subsequent 2 years (Siragusa S et al. Blood2005;106(11):OC262). At the present it is unknown whether RVT assessment may be used to select patients, with idiopathic DVT, who require screening for occult cancer. Objective of the study. We conducted a prospective study evaluating whether a RVT-based screening for cancer …

First episodemedicine.medical_specialtymedicine.diagnostic_testbusiness.industryDeep veinImmunologyCancerColonoscopySigmoidoscopyCell BiologyHematologymedicine.diseaseBiochemistrySurgeryVenous thrombosismedicine.anatomical_structureInternal medicineCohortmedicinebusinessProspective cohort studyBlood
researchProduct

Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI

2021

Hepatocellular carcinoma (HCC) may have an infiltrative appearance in about 8-20% of cases. Infiltrative HCC can be a challenging diagnosis and it is associated with the worst overall survival among HCC patients. Infiltrative HCC is characterized by the spread of multiple minute nodules throughout the liver, without a dominant one, ultimately resulting into macrovascular invasion. On CT and MRI, infiltrative HCC appears as an ill-defined, large mass, with variable degree of enhancement, and satellite neoplastic nodules in up to 52% of patients. On MRI, it may show restriction on diffusion weighted imaging, hyperintensity on T2- and hypointensity on T1-weighted images, and, if hepatobiliary …

Gadolinium DTPAmedicine.medical_specialtyCarcinoma HepatocellularHepatocellular carcinomaDifferential diagnosiContrast Media030218 nuclear medicine & medical imagingDiagnosis Differential03 medical and health sciences0302 clinical medicineMagnetic resonance imagingmedicineHumansRadiology Nuclear Medicine and imagingThrombusVeinComputed tomographyRetrospective Studiesmedicine.diagnostic_testbusiness.industryAmyloidosisLiver NeoplasmsMagnetic resonance imagingmedicine.diseaseThrombosisdigestive system diseasesHyperintensitymedicine.anatomical_structure030220 oncology & carcinogenesisHepatocellular carcinomaRadiologyDifferential diagnosisbusinessTomography X-Ray Computed
researchProduct

Clinical relevance of polymorphic markers of arterial thrombosis.

1997

Case-control and cross-sectional studies show that some common molecular variations (polymorphisms) of genes coding for proteins involved in atherosclerosis and thrombosis are often present in subjects who have experienced cerebrovascular or cardiovascular events. The clinical impact of the majority of polymorphic markers is disputed by prospective reports. In contrast, their pathophysiological implications and their role in monitoring parameters that are difficult to be checked by alternative means, are documented by the large majority of the reports. From the evidence available, there may be suggestion for further impact of polymorphic markers in vascular medicine. To substantiate this, n…

Genetic MarkersPathologymedicine.medical_specialtyPolymorphism GeneticGenetic inheritanceArterial diseaseVascular diseasebusiness.industryChromosome MappingThrombosisHematologyPeptidyl-Dipeptidase Amedicine.diseaseBioinformaticsThrombosisIschemiaRisk FactorsGenetic markermedicineHumansClinical significanceProspective cohort studybusinessVascular Medicine
researchProduct

Screening for multiple hereditary hypercoagulability factors using the amplification refractory mutation system

2003

Many hereditary factors have been implicated in the development of arterial and/or venous thromboembolic diseases. A number of these risk factors can be identified by the amplification refractory mutation system (ARMS). However, the underlying technical conditions for performing ARMS are highly variable, and depend on which risk factors are being analyzed. We have now developed a novel ARMS-based system to simultaneously screen for multiple hypercoagulability factors under identical PCR conditions. This can greatly simplify the process of screening for hereditary hypercoagulability.

GeneticsBase SequenceGenetic Carrier ScreeningHomozygoteGenetic Carrier ScreeningSingle-strand conformation polymorphismBlood ProteinsHematologyBlood Coagulation DisordersBiologymedicine.diseaseThrombophiliaBioinformaticsPolymerase Chain ReactionThrombosisBlood Coagulation FactorsRefractoryMutation (genetic algorithm)medicineCoagulopathyHumansMass ScreeningRisk factorDNA PrimersThrombosis Research
researchProduct